Proven performance for confident CFTR detection

Agena Bioscience has released a new technical white paper on the iPlex Pro® CFTR 100+ Panel, developed to support evolving cystic fibrosis (CF) research with expanded variant coverage. The panel includes all 100 CFTR variants recommended by the ACMG, along with 23 additional variants of interest.

The white paper outlines the analytical validation and verification studies performed across multiple laboratories using the MassARRAY® workflow. It provides insights into:

• Accuracy and analytical performance (concordance, sensitivity, and specificity)

• Robustness and reproducibility across instruments, operators, and conditions

• Reference materials and controls used during validation

This publication offers a clear overview of the panel’s performance under real-world laboratory conditions, making it a valuable resource for researchers and diagnostic laboratories.

For more information or to request the full white paper, please do not hesitate to contact us.